Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether isoniazid can safely (and further) reduce
the risk of tuberculosis in HIV infected people receiving HAART.
Phase:
N/A
Details
Lead Sponsor:
University of Cape Town
Collaborators:
Imperial College London Johns Hopkins University London School of Hygiene and Tropical Medicine Medecins Sans Frontieres, Netherlands